de Grey Aubrey D N J, Baynes John W, Berd David, Heward Christopher B, Pawelec Graham, Stock Gregory
Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, UK.
Bioessays. 2002 Jul;24(7):667-76. doi: 10.1002/bies.10113.
The feasibility of reversing human aging within a matter of decades has traditionally been dismissed by all professional biogerontologists, on the grounds that not only is aging still poorly understood, but also many of those aspects that we do understand are not reversible by any current or foreseeable therapeutic regimen. This broad consensus has recently been challenged by the publication, by five respected experimentalists in diverse subfields of biogerontology together with three of the present authors, of an article (Ann NY Acad Sci 959, 452-462) whose conclusion was that all the key components of mammalian aging are indeed amenable to substantial reversal (not merely retardation) in mice, with technology that has a reasonable prospect of being developed within about a decade. Translation of that panel of interventions to humans who are already alive, within a few decades thereafter, was deemed potentially feasible (though it was not claimed to be likely). If the prospect of controlling human aging within the foreseeable future cannot be categorically rejected, then it becomes a matter of personal significance to most people presently alive. Consequently, we suggest that serious public debate on this subject is now warranted, and we survey here several of the biological, social and political issues relating to it.
几十年来,逆转人类衰老的可行性一直被所有专业生物老年学家否定,理由是不仅衰老仍未被充分理解,而且我们所理解的许多方面也无法通过任何当前或可预见的治疗方案逆转。最近,这种广泛的共识受到了挑战,五位在生物老年学不同子领域备受尊敬的实验学家与本文三位作者共同发表了一篇文章(《纽约科学院学报》959卷,452 - 462页),其结论是哺乳动物衰老的所有关键组成部分在小鼠中确实可以通过在大约十年内有合理开发前景的技术实现大幅逆转(不仅仅是延缓)。在几十年后将该组干预措施应用于在世的人类被认为具有潜在可行性(尽管并未声称很有可能)。如果在可预见的未来控制人类衰老的前景不能被断然否定,那么这对目前在世的大多数人来说就具有个人意义。因此,我们认为现在有必要就这个问题展开严肃的公众辩论,并且我们在此审视与之相关的一些生物学、社会和政治问题。